This Fund aims to achieve long-term capital growth.
Name | % Net Assets |
---|---|
Microsoft | 2.9% |
Covidien | 2.7% |
Pfizer | 2.6% |
General Electric | 2.5% |
Apple | 2.4% |
Comcast | 2.4% |
Exelon | 2.4% |
Chevron | 2.3% |
PepsiCo | 2.2% |
Morgan Stanley | 2.0% |
Key | % Net Assets |
---|---|
Microsoft | 2.9% |
Covidien | 2.7% |
Pfizer | 2.6% |
General Electric | 2.5% |
Other | 89.3% |
Date | 20-Sep-2019 |
---|---|
NAV | 252.19p |
Currency | GBP |
Change | -1.34p |
% | -0.53% |
YTD change | 252.19p |
YTD % | n/a |
Fund Inception | 14/10/2002 |
---|---|
Fund Manager | Tom Digenan |
TER | 1.18 (31-Jan-2014) |
Minimum Investment | |
---|---|
Initial | £100000 |
Additional | £500 |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.00% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | -0.03 |
You are here: research